help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ino, K.
Right arrow Articles by Mizutani, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ino, K.
Right arrow Articles by Mizutani, S.
The Journal of Clinical Endocrinology & Metabolism Vol. 88, No. 8 3973-3982
Copyright © 2003 by The Endocrine Society

Enhancement of Aminopeptidase A Expression during Angiotensin II-Induced Choriocarcinoma Cell Proliferation through AT1 Receptor Involving Protein Kinase C- and Mitogen-Activated Protein Kinase-Dependent Signaling Pathway

Kazuhiko Ino, Carlos Uehara, Fumitaka Kikkawa, Hiroaki Kajiyama, Kiyosumi Shibata, Takahiro Suzuki, Ei Ei Khin, Mitsuaki Ito, Mikihito Takeuchi, Atsuo Itakura and Shigehiko Mizutani

Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan

Address all correspondence and requests for reprints to: Kazuhiko Ino, M.D., Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan. E-mail: kazuino{at}med.nagoya-u.ac.jp.

Angiotensin II (Ang II) is a bioactive peptide of the renin-angiotensin system, exerting its actions not only as a vasoconstrictor, but also as a growth promoter. In human placenta, type 1 Ang II receptors (AT1R) are predominantly expressed in trophoblasts, and we previously reported that aminopeptidase A (APA), a cell surface peptidase that converts Ang II to Ang III, is also expressed in both normal and neoplastic trophoblasts. However, the roles of Ang II and APA in trophoblast function remain to be clarified. In the present study we examined the effects of Ang II on proliferation and APA expression in trophoblast-like BeWo choriocarcinoma cells. Treatment of BeWo cells with Ang II significantly increased DNA synthesis in a dose-dependent manner. Ang II also enhanced APA mRNA and cell surface expression in BeWo cells analyzed by Northern blotting, flow cytometry, and enzyme activity assay. The Ang II-induced proliferation and APA up-regulation were blocked by the AT1R antagonist candesartan, but not by the AT2R antagonist PD123319. Furthermore, these Ang II effects were abolished by the protein kinase C inhibitor bisindolylmaleimide I and the MAPK inhibitor PD98059. Immunohistochemistry using choriocarcinoma tissues demonstrated that APA was expressed on the cell surface of AT1R-positive cytotrophoblastic cells in vivo. With these findings we demonstrate that Ang II stimulates the proliferation of trophoblastic cells via AT1R that are linked to protein kinase C /MAPK-dependent signaling pathways, and that the Ang II-degrading enzyme APA is up-regulated during Ang II-induced cell proliferation. These observations suggest the possible regulatory mechanism by the local renin-angiotensin system, especially the Ang II-AT1R-APA system, for the growth of human choriocarcinoma cells.

Abbreviations: ACE, Angiotensin-converting enzyme; Ang II, angiotensin II; APA, aminopeptidase A; AT1R, angiotensin type 1 receptor; AT2R, angiotensin type 2 receptor; BAPTA, 1,2-bis-(o-aminophenoxy)-ethane-N,N,N',N'-tetraacetic acid tetraacetic acid tetraacetoxymethyl ester; Bis I, bisindolylmaleimide I; BrdU, bromodeoxyuridine; EGFR, epidermal growth factor receptor; FACS, fluorescence-activated cell sorting; FCS, fetal calf serum; MTS, 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium; PKC, protein kinase C; RAS, renin-angiotensin system; VSMC, vascular smooth muscle cell.




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
L. Blanco, G. Larrinaga, I. Perez, J. I. Lopez, J. Gil, E. Agirregoitia, and A. Varona
Acid, basic, and neutral peptidases present different profiles in chromophobe renal cell carcinoma and in oncocytoma
Am J Physiol Renal Physiol, April 1, 2008; 294(4): F850 - F858.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
H. B.P.M. Dijkman, K. J.M. Assmann, E. J. Steenbergen, and J. F.M. Wetzels
Expression and Effect of Inhibition of Aminopeptidase-A during Nephrogenesis
J. Histochem. Cytochem., February 1, 2006; 54(2): 253 - 262.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. Suganuma, K. Ino, K. Shibata, H. Kajiyama, T. Nagasaka, S. Mizutani, and F. Kikkawa
Functional Expression of the Angiotensin II Type1 Receptor in Human Ovarian Carcinoma Cells and Its Blockade Therapy Resulting in Suppression of Tumor Invasion, Angiogenesis, and Peritoneal Dissemination
Clin. Cancer Res., April 1, 2005; 11(7): 2686 - 2694.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society